Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,960
Total Claims
$1.3M
Drug Cost
2,057
Beneficiaries
$630
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+31%
Opioid rate vs peers
60.0% vs 45.9% avg
+30%
Cost per patient vs peers
$630 vs $483 avg
+17%
Brand preference vs peers
4.8% vs 4.1% avg
Opioid Prescribing
60.0%
Opioid Rate
12,578
Opioid Claims
$670K
Opioid Cost
13.9%
Long-Acting Rate
This provider's opioid prescribing rate of 60.0% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,014 claims · $396K
Generic: 19,946 claims · $899K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Hydrocodone/Acetaminophen | 7,521 | $305K |
| Lidocaine | 378 | $115K |
| Fluocinonide | 418 | $105K |
| Oxycodone Myristate | 205 | $92K |
| Buprenorphine Hcl | 81 | $83K |
| Betamethasone/Propylene Glyc | 159 | $74K |
| Naloxegol Oxalate | 126 | $58K |
| Oxycodone Hcl/Acetaminophen | 1,210 | $49K |
| Linaclotide | 69 | $38K |
| Gabapentin | 1,836 | $33K |
| Naloxone Hcl | 306 | $26K |
| Morphine Sulfate | 1,064 | $26K |
| Oxycodone Hcl | 1,016 | $24K |
| Buprenorphine | 51 | $22K |
| Pregabalin | 623 | $22K |
Prescribing Profile
50
Unique Drugs
12.0
Anomaly Score
Patient Profile
67
Avg Age
68%
Female
2.53
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About